Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Cannabinor, a selective cannabinoid-2 receptor agonist, improves bladder emptying in rats with partial urethral obstruction.

Gratzke C, Streng T, Stief CG, Alroy I, Limberg BJ, Downs TR, Rosenbaum JS, Hedlund P, Andersson KE.

J Urol. 2011 Feb;185(2):731-6. doi: 10.1016/j.juro.2010.09.080. Epub 2010 Dec 18.

PMID:
21168864
2.

Effects of cannabinor, a novel selective cannabinoid 2 receptor agonist, on bladder function in normal rats.

Gratzke C, Streng T, Stief CG, Downs TR, Alroy I, Rosenbaum JS, Andersson KE, Hedlund P.

Eur Urol. 2010 Jun;57(6):1093-100. doi: 10.1016/j.eururo.2010.02.027. Epub 2010 Mar 1.

PMID:
20207474
3.

Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine.

Yang Z, Aubrey KR, Alroy I, Harvey RJ, Vandenberg RJ, Lynch JW.

Biochem Pharmacol. 2008 Oct 15;76(8):1014-23. doi: 10.1016/j.bcp.2008.07.037. Epub 2008 Aug 7.

PMID:
18755158
4.

The ubiquitin E3 ligase POSH regulates calcium homeostasis through spatial control of Herp.

Tuvia S, Taglicht D, Erez O, Alroy I, Alchanati I, Bicoviski V, Dori-Bachash M, Ben-Avraham D, Reiss Y.

J Cell Biol. 2007 Apr 9;177(1):51-61.

5.

A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas.

Alchanati I, Nallar SC, Sun P, Gao L, Hu J, Stein A, Yakirevich E, Konforty D, Alroy I, Zhao X, Reddy SP, Resnick MB, Kalvakolanu DV.

Oncogene. 2006 Nov 16;25(54):7138-47. Epub 2006 May 29.

PMID:
16732315
6.

Biochemistry of HER2 oncogenesis in breast cancer.

Alroy I, Yarden Y.

Breast Dis. 2000;11:31-48.

PMID:
15687591
7.

The trans-Golgi network-associated human ubiquitin-protein ligase POSH is essential for HIV type 1 production.

Alroy I, Tuvia S, Greener T, Gordon D, Barr HM, Taglicht D, Mandil-Levin R, Ben-Avraham D, Konforty D, Nir A, Levius O, Bicoviski V, Dori M, Cohen S, Yaar L, Erez O, Propheta-Meiran O, Koskas M, Caspi-Bachar E, Alchanati I, Sela-Brown A, Moskowitz H, Tessmer U, Schubert U, Reiss Y.

Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1478-83. Epub 2005 Jan 19.

8.

Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding.

Amit I, Yakir L, Katz M, Zwang Y, Marmor MD, Citri A, Shtiegman K, Alroy I, Tuvia S, Reiss Y, Roubini E, Cohen M, Wides R, Bacharach E, Schubert U, Yarden Y.

Genes Dev. 2004 Jul 15;18(14):1737-52.

9.

Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy.

Citri A, Alroy I, Lavi S, Rubin C, Xu W, Grammatikakis N, Patterson C, Neckers L, Fry DW, Yarden Y.

EMBO J. 2002 May 15;21(10):2407-17.

10.

Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome.

Bao J, Alroy I, Waterman H, Schejter ED, Brodie C, Gruenberg J, Yarden Y.

J Biol Chem. 2000 Aug 25;275(34):26178-86.

11.

Potential reduction of costs and hospital emergency department visits resulting from prehospital transtelephonic triage--the Shahal experience in Israel.

Roth A, Malov N, Carthy Z, Golovner M, Naveh R, Alroy I, Kaplinsky E, Laniado S.

Clin Cardiol. 2000 Apr;23(4):271-6.

12.

Medical history of hypercholesterolaemia adversely affects the outcome of out-of-hospital cardiopulmonary resuscitation; the 'Shahal' experience in Israel.

Roth A, Golovner M, Gavish D, Shapira I, Malov N, Sender J, Alroy I, Kaplinski E, Laniado S.

Eur Heart J. 2000 May;21(9):778-81.

PMID:
10739734
13.

Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1.

Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, Lipkowitz S, Yarden Y.

Mol Cell. 1999 Dec;4(6):1029-40.

14.

Circadian variation of symptomatic paroxysmal atrial fibrillation. Data from almost 10 000 episodes.

Viskin S, Golovner M, Malov N, Fish R, Alroy I, Vila Y, Laniado S, Kaplinsky E, Roth A.

Eur Heart J. 1999 Oct;20(19):1429-34.

PMID:
10487804
15.

The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor.

Waterman H, Levkowitz G, Alroy I, Yarden Y.

J Biol Chem. 1999 Aug 6;274(32):22151-4.

16.
17.

The "telepress" system for self-measurement and monitoring of blood pressure (the "SHAHAL" experience in Israel).

Roth A, Golovner M, Malov N, Carthy Z, Naveh R, Alroy I, Kaplinsky E, Laniado S.

Am J Cardiol. 1999 Feb 15;83(4):610-2, A10.

PMID:
10073874
18.

Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor.

Alroy I, Soussan L, Seger R, Yarden Y.

Mol Cell Biol. 1999 Mar;19(3):1961-72.

19.

ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.

Pinkas-Kramarski R, Shelly M, Guarino BC, Wang LM, Lyass L, Alroy I, Alimandi M, Kuo A, Moyer JD, Lavi S, Eisenstein M, Ratzkin BJ, Seger R, Bacus SS, Pierce JH, Andrews GC, Yarden Y.

Mol Cell Biol. 1998 Oct;18(10):6090-101. Erratum in: Mol Cell Biol 1998 Dec;18(12):7602. Alamandi M [corrected to Alimandi M].

20.

Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation.

Pinkas-Kramarski R, Eilam R, Alroy I, Levkowitz G, Lonai P, Yarden Y.

Oncogene. 1997 Dec 4;15(23):2803-15.

21.

Bivalence of EGF-like ligands drives the ErbB signaling network.

Tzahar E, Pinkas-Kramarski R, Moyer JD, Klapper LN, Alroy I, Levkowitz G, Shelly M, Henis S, Eisenstein M, Ratzkin BJ, Sela M, Andrews GC, Yarden Y.

EMBO J. 1997 Aug 15;16(16):4938-50.

23.

ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling.

Pinkas-Kramarski R, Alroy I, Yarden Y.

J Mammary Gland Biol Neoplasia. 1997 Apr;2(2):97-107. Review.

PMID:
10882296
24.

Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

Pinkas-Kramarski R, Soussan L, Waterman H, Levkowitz G, Alroy I, Klapper L, Lavi S, Seger R, Ratzkin BJ, Sela M, Yarden Y.

EMBO J. 1996 May 15;15(10):2452-67.

26.

Stereochemistry of specific steroid receptor-DNA interactions.

Xu W, Alroy I, Freedman LF, Sigler PB.

Cold Spring Harb Symp Quant Biol. 1993;58:133-9. No abstract available.

PMID:
7956023
27.

DNA binding analysis of glucocorticoid receptor specificity mutants.

Alroy I, Freedman LP.

Nucleic Acids Res. 1992 Mar 11;20(5):1045-52.

Supplemental Content

Support Center